The Meandrous Route of Rilpivirine in the Search for the Miraculous Drug to Treat HIV Infections. [PDF]
De Clercq E.
europepmc +1 more source
Reversible Severe Hyperglycemia Without Ketoacidosis After Initiation of Bictegravir-containing Antiretroviral Therapy. [PDF]
Aurora J +4 more
europepmc +1 more source
Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women. [PDF]
Briceño-Patiño N +4 more
europepmc +1 more source
Orthostatic hypotension in a patient with HIV: uncovering adrenal insufficiency from fluticasone-cobicistat interactions. [PDF]
Dienes S, Nunn R, Lai A.
europepmc +1 more source
2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings. [PDF]
Kofman AD +10 more
europepmc +1 more source
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg. [PDF]
Natukunda E +12 more
europepmc +1 more source
Contemporary Antiretroviral Therapy Regimens in People With HIV Who Initiated Treatment in the Pre-Antiretroviral Therapy Era. [PDF]
Adachi E +4 more
europepmc +1 more source
Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity considerations. [PDF]
Chess I +4 more
europepmc +1 more source
Immediate and delayed switches to tenofovir DF-containing, ainuovirine-based antiretroviral regimen: the SPRINT extensional study. [PDF]
Zhang F +15 more
europepmc +1 more source

